Twitter’s algorithm changes likely mean fewer consumers will see a brand’s tweets.
L’Oreal USA will acquire device maker and online retailer Pacific Bioscience.
L’Oreal USA, a unit of L’Oreal SA, has acquired Pacific Bioscience Laboratories Inc., a manufacturer and online retailer of sonic skin care devices.
L’Oreal, an international manufacturer of cosmetics and related personal care products, didn’t announce the terms of the deal. But L’Oreal did say the acquisition of Pacific Bioscience, which generates annual sales of $105 million and sells online at Clarisonic.com, will help L’Oreal develop new business opportunities in the niche market of sonic devices that consumers, spas, salons and others use for skin care treatment.
“Clarisonic is a strategic acquisition for L’Oreal,” says L’Oreal president Nicolas Hieronymus. “Devices are emerging globally as an important new skin care category. Clarisonic is the most successful and fast-growing premium brand in this category and we will roll it out internationally as well as enhance our service experience in our luxury counters.”
Pacific Bioscience, will become a part of L’Oreal USA, but will maintain its headquarters, manufacturing and research facility near Seattle. Pacific Bioscience CEO David Giuliani also will remain in his current position, L’Oreal says.
L’Oreal USA has sales of over $4.7 billion and is a wholly owned subsidiary of L’Oreal SA. L’Oreal USA has research, manufacturing and distribution facilities in New Jersey, Kentucky, Arkansas, Illinois, Ohio and Texas.
Clarisonic is distributed through dermatologists, cosmetic surgeons, spas and retailers such as Sephora, Nordstrom, QVC, Saks Fifth Avenue, Ulta, Beauty.com and SkinStore.com. Beauty.com and Skinstore.com are a part of Drugstore.com, which was acquired by Walgreen Co., No. 73 in the Internet Retailer Top 500 Guide in June.